153 related articles for article (PubMed ID: 9885303)
1. Biopharmaceutical characterization of oral immediate release drug products. In vitro/in vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin.
Frick A; Möller H; Wirbitzki E
Eur J Pharm Biopharm; 1998 Nov; 46(3):305-11. PubMed ID: 9885303
[TBL] [Abstract][Full Text] [Related]
2. Strategies to improve dissolution and oral absorption of glimepiride tablets: solid dispersion versus micronization techniques.
Ning X; Sun J; Han X; Wu Y; Yan Z; Han J; He Z
Drug Dev Ind Pharm; 2011 Jun; 37(6):727-36. PubMed ID: 21204747
[TBL] [Abstract][Full Text] [Related]
3. Biowaiver monographs for immediate release solid oral dosage forms: levofloxacin.
Koeppe MO; Cristofoletti R; Fernandes EF; Storpirtis S; Junginger HE; Kopp S; Midha KK; Shah VP; Stavchansky S; Dressman JB; Barends DM
J Pharm Sci; 2011 May; 100(5):1628-36. PubMed ID: 21374601
[TBL] [Abstract][Full Text] [Related]
4. [Preparation and evaluation in vivo and in vitro of glimepiride gel-matrix controlled-release patch].
Zhang Y; Xu DH; Ma Z; Chen Y; Zhao JJ; Xu SB
Yao Xue Xue Bao; 2004 Aug; 39(8):640-4. PubMed ID: 15563069
[TBL] [Abstract][Full Text] [Related]
5. The influence of caprate on rectal absorption of phenoxymethylpenicillin: experience from an in-vivo perfusion in humans.
Lennernäs H; Gjellan K; Hallgren R; Graffner C
J Pharm Pharmacol; 2002 Apr; 54(4):499-508. PubMed ID: 11999127
[TBL] [Abstract][Full Text] [Related]
6. Formulation and biological evaluation of glimepiride-cyclodextrin-polymer systems.
Ammar HO; Salama HA; Ghorab M; Mahmoud AA
Int J Pharm; 2006 Feb; 309(1-2):129-38. PubMed ID: 16377107
[TBL] [Abstract][Full Text] [Related]
7. New formulation approaches to improve solubility and drug release from fixed dose combinations: case examples pioglitazone/glimepiride and ezetimibe/simvastatin.
Taupitz T; Dressman JB; Klein S
Eur J Pharm Biopharm; 2013 May; 84(1):208-18. PubMed ID: 23246797
[TBL] [Abstract][Full Text] [Related]
8. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery.
Gioumouxouzis CI; Baklavaridis A; Katsamenis OL; Markopoulou CK; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2018 Jul; 120():40-52. PubMed ID: 29678613
[TBL] [Abstract][Full Text] [Related]
9. A discriminating dissolution method for glimepiride polymorphs.
Bonfilio R; Pires SA; Ferreira LM; de Almeida AE; Doriguetto AC; de Araújo MB; Salgado HR
J Pharm Sci; 2012 Feb; 101(2):794-804. PubMed ID: 22052673
[TBL] [Abstract][Full Text] [Related]
10. Biopharmaceutical characterization of sotalol-containing oral immediate release drug products.
Alt A; Potthast H; Moessinger J; Sickmüller B; Oeser H
Eur J Pharm Biopharm; 2004 Jul; 58(1):145-50. PubMed ID: 15207548
[TBL] [Abstract][Full Text] [Related]
11. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: Preparation, characterization, in vitro, ex vivo and clinical evaluation.
Ahmed TA; El-Say KM; Aljaeid BM; Fahmy UA; Abd-Allah FI
Int J Pharm; 2016 Mar; 500(1-2):245-54. PubMed ID: 26775063
[TBL] [Abstract][Full Text] [Related]
12. Eudragit-based nanosuspension of poorly water-soluble drug: formulation and in vitro-in vivo evaluation.
Yadav SK; Mishra S; Mishra B
AAPS PharmSciTech; 2012 Dec; 13(4):1031-44. PubMed ID: 22893314
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of biowaiver extension to biopharmaceutics classification system class III drug products: cimetidine.
Jantratid E; Prakongpan S; Amidon GL; Dressman JB
Clin Pharmacokinet; 2006; 45(4):385-99. PubMed ID: 16584285
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of a fixed-dose glimepiride/sustained-release metformin combination.
Kim KP; Lim KS; Kim BH; Shin HS; Cho JY; Shin SG; Jang IJ; Yu KS
Int J Clin Pharmacol Ther; 2012 Feb; 50(2):142-9. PubMed ID: 22257580
[TBL] [Abstract][Full Text] [Related]
15. Design and evaluation of chitosan films for transdermal delivery of glimepiride.
Ammar HO; Salama HA; El-Nahhas SA; Elmotasem H
Curr Drug Deliv; 2008 Oct; 5(4):290-8. PubMed ID: 18855598
[TBL] [Abstract][Full Text] [Related]
16. Improvement of gliquidone hypoglycaemic effect in rats by cyclodextrin formulations.
Miro A; Quaglia F; Sorrentino U; La Rotonda MI; D'Emmanuele Di Villa Bianca R; Sorrentino R
Eur J Pharm Sci; 2004 Sep; 23(1):57-64. PubMed ID: 15324923
[TBL] [Abstract][Full Text] [Related]
17. Solid self-nanoemulsifying drug delivery system (S-SNEDDS) for oral delivery of glimepiride: development and antidiabetic activity in albino rabbits.
Mohd AB; Sanka K; Bandi S; Diwan PV; Shastri N
Drug Deliv; 2015; 22(4):499-508. PubMed ID: 24471856
[TBL] [Abstract][Full Text] [Related]
18. Synthesized nano particles of glimepiride via spray freezing into cryogenic liquid: characterization, antidiabetic activity, and bioavailability.
Gaber DA; Alhuwaymili AS; Alhawas HS; Almutiri AA; Alsubaiyel AM; Abdoun SA; Almutairi RA
Drug Deliv; 2022 Dec; 29(1):364-373. PubMed ID: 35068278
[TBL] [Abstract][Full Text] [Related]
19. Effect of Coadministered Water on the In Vivo Performance of Oral Formulations Containing N-Acetylcysteine: An In Vitro Approach Using the Dynamic Open Flow-Through Test Apparatus.
Sager M; Schneider F; Jedamzik P; Wiedmann M; Schremmer E; Koziolek M; Weitschies W
Mol Pharm; 2017 Dec; 14(12):4272-4280. PubMed ID: 29064257
[TBL] [Abstract][Full Text] [Related]
20. Development and characterization of glimepiride nanocrystal formulation and evaluation of its pharmacokinetic in rats.
Du B; Shen G; Wang D; Pang L; Chen Z; Liu Z
Drug Deliv; 2013; 20(1):25-33. PubMed ID: 23311650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
